Evidence map›Paper›PMID 26467255›Full record

ArticleCirculation2015

Atherothrombosis: Seeing Red?

Daniel I Simon, Roy L Silverstein

Abstract readEditorialComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Circulation, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. MicroRNA profiling of diabetic atherosclerosis in a rat model.European journal of medical research · 2018
    Article
  5. Potential therapeutic effects of mTOR inhibition in atherosclerosis.British journal of clinical pharmacology · 2016
    Review
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

Daniel I SimonFrom Harrington Heart & Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH (D.I.S.); and Department of Medicine, Medical College of Wisconsin and Blood Research Institute, Blood Center of Wisconsin, Milwaukee (R.L.S.). Daniel.simon@uhhospitals.org.
Roy L SilversteinFrom Harrington Heart & Vascular Institute, University Hospitals Case Medical Center, Case Western Reserve University School of Medicine, Cleveland, OH (D.I.S.); and Department of Medicine, Medical College of Wisconsin and Blood Research Institute, Blood Center of Wisconsin, Milwaukee (R.L.S.).

Funding

Inflammation in Vascular Injury and RepairR37HL057506 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI SIMON, DANIEL I · 2007 to 2016
$4.1M
Inflammation in Vascular Injury and RepairR01HL057506 · NHLBI · CASE WESTERN RESERVE UNIVERSITY · PI SIMON, DANIEL I · 1997 to 2006
$2.4M
Mechanistic Role of CD36 in ThrombosisR01HL111614 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI SILVERSTEIN, ROY L · 2013 to 2017
$1.7M
NHLBI NIH HHS HL057506NHLBI NIH HHS HL111614NHLBI NIH HHS R01 HL057506NHLBI NIH HHS R01 HL111614NHLBI NIH HHS R37 HL057506
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsAtherosclerosisDiet, High-FatErythrocytesObesityatherosclerosisEditorialsphysiopathologyred blood cellsthrombosis

Identifiers

PMID26467255
PMCPMC4651722

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.